Table 3 Clinical, laboratory, and radiological data in both groups, on admission

 SBP (mmHg), mean ± SD

133.5 ± 22.3

146.1 ± 23.0

0.026

 DBP (mmHg), mean ± SD

85.9 ± 13.7

88.6 ± 10.4

0.291

Temperature, mean ± SD

37.2 ± 0.3

37.1 ± 0.2

0.121

Respiratory rate, mean ± SD

17.2 ± 1.4

17.0 ± 1.2

0.502

Pulse, mean ± SD

81.1 ± 12.4

79.1 ± 11.5

0.433

Seizures, n (%)

5 (62.5%)

3 (37.5%)

0.407

Aphasia, n (%)

13 (68.4%)

6 (31.6%)

0.047

Dysarthria, n (%)

11 (52.4%)

10 (47.6%)

0.625

Motor weakness, n (%)

27 (43.5%)

35 (56.5%)

0.369

Ataxia, n (%)

2 (50%)

2 (50%)

0.920

GCS, mean ± SD

13.84 ± 1.86

13.93 ± 1.87

0.813

NIHSS, mean ± SD

8.80 ± 5.03

7.77 ± 4.60

0.277

SSS, mean ± SD

47.80 ± 9.19

48.57 ± 7.91

0.643

 Large artery atherosclerosis, n (%)

10 (17.2%)

8 (12.5%)

0.008

 Cardioembolic, n (%)

21 (36.2%)

8 (12.5%)

 Small vessel, n (%)

20 (34.5%)

37 (57.8%)

 Undetermined (%)

7 (12.1%)

11 (17.2%)

Blood sugar, mean ± SD

181.81 ± 37.28

194.53 ± 49.94

0.119

Creatinine, mean ± SD

1.03 ± 0.51

1.24 ± 0.82

0.129

RBCs, mean ± SD

4.71 ± 0.63

4.68 ± 0.70

0.300

HGB, mean ± SD

12.34 ± 2.22

12.68 ± 1.70

0.381

WBCs, mean ± SD

9.35 ± 3.7

8.94 ± 4.9

0.175

Platelets, mean ± SD

203.86 ± 60.48

205.98 ± 65.48

0.777

ESR, mean ± SD

32.77 ± 20.81

36.64 ± 26.62

0.753

Cholesterol, mean ± SD

160.14 ± 51.56

173.92 ± 42.47

0.146

Triglyceride, mean ± SD

117.00 ± 79.49

163.16 ± 200.65

0.138

Uric acid, mean ± SD

5.60 ± 1.49

5.68 ± 1.87

0.820

 Diffuse atherosclerotic changes, n (%)

21 (36.2%)

12 (18.8%)

0.030

 Atheromatous plaque with non-significant stenosis, n (%)

9 (15.5%)

17 (26.6%)

0.137

 Atheromatous plaque with significant stenosis, n (%)

9 (15.5%)

7 (10.9%)

0.454

 Valvular heart disease

16 (27.6%)

7 (10.9%)

0.019

 LVH

18 (31%)

30 (46.9%)

0.074